LumiraDX Ltd.
(NASDAQ : LMDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.54%592.851.0%$746.92m
DHRDanaher Corp. -1.09%294.030.7%$616.72m
ISRGIntuitive Surgical, Inc. -0.34%228.920.8%$501.52m
MDTMedtronic Plc -0.14%94.780.6%$432.76m
ABTAbbott Laboratories -1.07%109.370.8%$429.68m
SYKStryker Corp. -0.75%219.771.3%$367.69m
BSXBoston Scientific Corp. 0.15%42.501.0%$304.90m
DXCMDexCom, Inc. -1.28%87.011.9%$260.96m
ALGNAlign Technology, Inc. 1.35%281.406.4%$260.65m
EWEdwards Lifesciences Corp. -1.59%98.940.4%$249.90m
BDXBecton, Dickinson & Co. -0.61%262.611.0%$231.14m
IDXXIDEXX Laboratories, Inc. -0.08%373.703.9%$219.14m
AAgilent Technologies, Inc. -1.95%139.511.7%$200.48m
BAXBaxter International, Inc. -1.52%60.451.8%$198.89m
MASIMasimo Corp. -3.24%160.185.1%$191.53m

Company Profile

LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm's diagnostic testing solutions are being deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. It also has a comprehensive portfolio of COVID-19 testing solutions from the lab to point of need. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.